M. Neuvonen

发表

Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole

P. Neuvonen, M. Niemi, K. Raaska, 2002, Clinical pharmacology and therapeutics.

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.

P. Neuvonen, J. Backman, M. Neuvonen, 2002, Drug metabolism and disposition: the biological fate of chemicals.

Gemfibrozil greatly increases plasma concentrations of cerivastatin

P. Neuvonen, J. Backman, M. Neuvonen, 2002, Clinical pharmacology and therapeutics.

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

Mikko Niemi, P. Neuvonen, M. Niemi, 2006, Pharmacogenetics and genomics.

St John's wort greatly reduces the concentrations of oral oxycodone

P. Neuvonen, K. Laine, M. Neuvonen, 2010, European journal of pain.

Rifampin Greatly Reduces the Plasma Concentrations of Intravenous and Oral Oxycodone

P. Neuvonen, A. Pertovaara, K. Laine, 2009, Anesthesiology.

CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe

P. Neuvonen, M. Niemi, J. Backman, 2009, Drug Metabolism and Disposition.

Autoinhibition of CYP3A4 Leads to Important Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

P. Neuvonen, J. Backman, M. Neuvonen, 2013, Drug Metabolism and Disposition.

Autoinhibition of CYP 3 A 4 Leads to Important Role of CYP 2 C 8 in Imatinib Metabolism : Variability in CYP 2 C 8 Activity May Alter Plasma Concentrations and Response s

P. Neuvonen, J. Backman, M. Neuvonen, 2012 .

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

P. Neuvonen, M. Niemi, J. Backman, 2003, Clinical pharmacology and therapeutics.

No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.

P. Neuvonen, M. Niemi, M. Neuvonen, 2008, British journal of clinical pharmacology.

The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range.

P. Neuvonen, M. Niemi, M. Neuvonen, 2008, British journal of clinical pharmacology.

Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinide

P. Neuvonen, M. Niemi, J. Backman, 2003, Clinical pharmacology and therapeutics.

Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

P. Neuvonen, M. Niemi, J. Backman, 2001, Clinical pharmacology and therapeutics.

The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.

P. Neuvonen, M. Niemi, J. Backman, 2004, British journal of clinical pharmacology.

The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism‐based Inhibition of CYP2C8 In Vivo

M. Niemi, J. Backman, M. Neuvonen, 2008, Clinical pharmacology and therapeutics.

Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction

P. Neuvonen, M. Scheinin, M. Turpeinen, 2012, European Journal of Clinical Pharmacology.

Effect of grapefruit juice on the bioactivation of prasugrel.

P. Neuvonen, M. Niemi, J. Backman, 2015, British journal of clinical pharmacology.

Grapefruit juice enhances the exposure to oral oxycodone.

P. Neuvonen, K. Laine, M. Neuvonen, 2010, Basic & clinical pharmacology & toxicology.

Fluvoxamine Drastically Increases Concentrations and Effects of Tizanidine: A Potentially Hazardous Interaction

P. Neuvonen, J. Backman, M. Neuvonen, 2004, Clinical pharmacology and therapeutics.

Rifampin decreases the plasma concentrations and effects of repaglinide

P. Neuvonen, M. Niemi, J. Backman, 2000, Clinical pharmacology and therapeutics.

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel

P. Neuvonen, M. Niemi, J. Backman, 2018, Clinical pharmacology and therapeutics.

Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects.

P. Neuvonen, M. Niemi, J. Backman, 2013, British journal of clinical pharmacology.

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans

P. Neuvonen, M. Niemi, J. Backman, 2009, Pharmacogenetics and genomics.

Effect of rifampicin on the pharmacokinetics of pioglitazone.

P. Neuvonen, J. Backman, M. Neuvonen, 2006, British journal of clinical pharmacology.

Ciprofloxacin greatly increases concentrations and cypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2–mediated presystemic metabolism

P. Neuvonen, J. Backman, M. Neuvonen, 2004, Clinical pharmacology and therapeutics.

Elimination of Intravenous Oxycodone in the Elderly

P. Neuvonen, R. Aantaa, M. Neuvonen, 2011, Drugs & aging.

Response to “Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?”

P. Neuvonen, M. Niemi, J. Backman, 2018, Clinical pharmacology and therapeutics.

Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions

P. Neuvonen, M. Niemi, J. Backman, 2018, Drug Metabolism and Disposition.

Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel

M. Niemi, M. Neuvonen, P. Neuvonen, 2014, Clinical pharmacology and therapeutics.

CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel

P. Neuvonen, M. Niemi, J. Backman, 2018, Clinical pharmacology and therapeutics.

Voriconazole drastically increases exposure to oral oxycodone

P. Neuvonen, K. Laine, M. Neuvonen, 2009, European Journal of Clinical Pharmacology.

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum

A. Dicko, T. Bousema, M. Niemi, 2019, Antimicrobial Agents and Chemotherapy.

Paroxetine Markedly Increases Plasma Concentrations of Ophthalmic Timolol; CYP2D6 Inhibitors May Increase the Risk of Cardiovascular Adverse Effects of 0.5% Timolol Eye Drops

P. Neuvonen, M. Niemi, J. Backman, 2014, Drug Metabolism and Disposition.

Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat

E. Kalso, M. Niemi, E. Kalso, 2015, British journal of pharmacology.

The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

E. Kalso, M. Niemi, M. Neuvonen, 2014, European journal of pain.

Itraconazole, a potent inhibitor of P‐glycoprotein, moderately increases plasma concentrations of oral morphine

E. Kalso, P. Neuvonen, J. Backman, 2008, Acta anaesthesiologica Scandinavica.

High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma.

P. Neuvonen, M. Niemi, M. Neuvonen, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone

P. Neuvonen, M. Niemi, J. Backman, 2016, Drug Metabolism and Disposition.

Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8

J. Backman, M. Neuvonen, R. Totah, 2019, Drug Metabolism and Disposition.

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

P. Neuvonen, K. Laine, M. Neuvonen, 2010, European Journal of Clinical Pharmacology.

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

P. Neuvonen, K. Laine, M. Neuvonen, 2010, European Journal of Clinical Pharmacology.

Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.

P. Neuvonen, J. Backman, M. Neuvonen, 2006, British journal of clinical pharmacology.

Plasma Concentrations of Oral Oxycodone Are Greatly Increased in the Elderly

P. Neuvonen, R. Aantaa, R. Aantaa, 2008, Clinical pharmacology and therapeutics.

Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone

P. Neuvonen, M. Niemi, J. Backman, 2006, European Journal of Clinical Pharmacology.

Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients

E. Kalso, P. Neuvonen, V. Kontinen, 2010, Scandinavian journal of pain.

Pharmacokinetics and Pharmacodynamics of Pravastatin in Pediatric and Adolescent Cardiac Transplant Recipients on a Regimen of Triple Immunosuppression

P. Neuvonen, M. Neuvonen, C. Holmberg, 2004, Clinical pharmacology and therapeutics.

Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans

P. Neuvonen, M. Niemi, J. Backman, 2012, Clinical pharmacology and therapeutics.

Autoinhibition of CYP3A4 Leads to Major Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

P. Neuvonen, J. Backman, M. Neuvonen, 2012 .

Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia

P. Neuvonen, M. Neuvonen, Mia Hedman, 2003, Clinical pharmacology and therapeutics.

Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.

P. Neuvonen, M. Niemi, J. Backman, 2005, British journal of clinical pharmacology.

Effects of Gemfibrozil, Itraconazole, and Their Combination on the Pharmacokinetics of Pioglitazone

P. Neuvonen, J. Backman, M. Neuvonen, 2005, Clinical pharmacology and therapeutics.

Glucuronidation Converts Clopidogrel to a Strong Time‐Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions

P. Neuvonen, M. Niemi, J. Backman, 2014, Clinical pharmacology and therapeutics.

Determination of Oxycodone, Noroxycodone, Oxymorphone, and Noroxymorphone in Human Plasma by Liquid Chromatography-Electrospray-Tandem Mass Spectrometry

P. Neuvonen, M. Neuvonen, 2008, Therapeutic drug monitoring.

An Automated Cocktail Method for In Vitro Assessment of Direct and Time-Dependent Inhibition of Nine Major Cytochrome P450 Enzymes - Application to Establishing CYP2C8 Inhibitor Selectivity.

M. Niemi, J. Backman, M. Neuvonen, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Polymorphic Organic Anion Transporting Polypeptide 1B1 is a Major Determinant of Repaglinide Pharmacokinetics

Mikko Niemi, Michel Eichelbaum, P. Neuvonen, 2005, Clinical pharmacology and therapeutics.

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

P. Neuvonen, M. Niemi, J. Backman, 2004, Pharmacogenetics.

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics

M. Niemi, J. Backman, M. Neuvonen, 2022, British journal of clinical pharmacology.

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

P. Neuvonen, M. Niemi, M. Eichelbaum, 2006, British journal of clinical pharmacology.

Rifampicin markedly decreases the exposure to oral and intravenous tramadol

P. Neuvonen, M. Scheinin, K. Laine, 2013, European Journal of Clinical Pharmacology.

Extraesophageal reflux and reflux aspiration in dogs with respiratory diseases and in healthy dogs

M. Neuvonen, S. Holopainen, M. Rajamäki, 2023, Journal of veterinary internal medicine.

Reflux aspiration in lungs of dogs with respiratory disease and in healthy West Highland White Terriers

M. Neuvonen, S. Holopainen, M. Rajamäki, 2018, Journal of veterinary internal medicine.

Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition

P. Pajukanta, M. Niemi, M. Nieuwdorp, 2020, Hepatology communications.

Circulating oxylipin and bile acid profiles of dexmedetomidine, propofol, sevoflurane, and S-ketamine: a randomised controlled trial using tandem mass spectrometry

M. Perola, A. Revonsuo, M. Niemi, 2022, BJA open.

Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction

P. Neuvonen, M. Niemi, J. Backman, 2019, Clinical and translational science.

Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

P. Neuvonen, M. Neuvonen, J. Lilja, 2004, British journal of clinical pharmacology.

Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin

M. Niemi, J. Backman, T. Jaatinen, 2020, Clinical and translational science.

Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins

M. Niemi, M. Neuvonen, Feng Deng, 2021, Drug Metabolism and Disposition.

Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance

P. Neuvonen, J. Backman, M. Neuvonen, 2003, Clinical pharmacology and therapeutics.

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

P. Neuvonen, J. Backman, M. Neuvonen, 2001, Clinical pharmacology and therapeutics.

Comparative Hepatic and Intestinal Efflux Transport of Statins

M. Niemi, M. Neuvonen, S. Oswald, 2021, Drug Metabolism and Disposition.

Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis

M. Färkkilä, M. Neuvonen, P. Kärkkäinen, 2006, Alimentary pharmacology & therapeutics.

Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations

P. Neuvonen, J. Backman, M. Neuvonen, 2000, Clinical pharmacology and therapeutics.

Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl

P. Neuvonen, K. Laine, M. Neuvonen, 2007, European Journal of Clinical Pharmacology.

Enantiospecific Pharmacogenomics of Fluvastatin

M. Niemi, J. Backman, H. Kidron, 2019, Clinical pharmacology and therapeutics.

Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate Simvastatin

P. Neuvonen, M. Niemi, J. Backman, 2015, Drug Metabolism and Disposition.

SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid

P. Neuvonen, M. Niemi, J. Backman, 2015, Pharmacogenetics and genomics.

has no clinically meaningful effect on the pharmacokinetics of the OATP1B1 and CYP3A4 substrate simvastatin

P. Neuvonen, M. Niemi, M. Neuvonen, 2015 .

No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

P. Neuvonen, M. Niemi, J. Backman, 2009, British journal of clinical pharmacology.

Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics

C. Funck-Brentano, M. Neuvonen, C. Verstuyft, 2007, Clinical pharmacology and therapeutics.

Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans

M. Niemi, J. Backman, M. Neuvonen, 2021, Clinical pharmacology and therapeutics.

Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers

A. D. Rodrigues, M. Niemi, M. Varma, 2020, Clinical pharmacology and therapeutics.

Cyclosporine markedly raises the plasma concentrations of repaglinide

P. Neuvonen, M. Niemi, J. Backman, 2005, Clinical pharmacology and therapeutics.

Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.

P. Neuvonen, J. Backman, M. Neuvonen, 2003, British journal of clinical pharmacology.

GEMFIBROZIL INHIBITS CYP 2 C 8-MEDIATED CERIVASTATIN METABOLISM IN HUMAN LIVER MICROSOMES

P. Neuvonen, J. Backman, M. Neuvonen, 2002 .

Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid

P. Neuvonen, T. Mjörndal, M. Neuvonen, 2004, European Journal of Clinical Pharmacology.

Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites

P. Neuvonen, J. Backman, M. Neuvonen, 2005, Clinical pharmacology and therapeutics.

Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans

P. Neuvonen, M. Niemi, J. Backman, 2015, Clinical pharmacology and therapeutics.

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

P. Neuvonen, M. Niemi, J. Backman, 2003, Diabetologia.

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

P. Neuvonen, M. Niemi, J. Backman, 2003, Diabetologia.

UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics—A Comprehensive Pharmacogenomic Study

M. Niemi, J. Backman, M. Neuvonen, 2020, Clinical pharmacology and therapeutics.

Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers

M. Niemi, J. Backman, M. Neuvonen, 2020, Anesthesia and analgesia.

Type : Article Enantiospecific pharmacogenomics of fluvastatin

M. Niemi, J. Backman, M. Neuvonen, 2019 .

Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans

P. Neuvonen, M. Niemi, J. Backman, 2017, Clinical pharmacology and therapeutics.

Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs.

M. Niemi, H. Kidron, M. Neuvonen, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects

P. Neuvonen, M. Niemi, J. Backman, 2018, Basic & clinical pharmacology & toxicology.

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects.

P. Neuvonen, M. Niemi, J. Backman, 2003, British journal of clinical pharmacology.

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

P. Neuvonen, M. Niemi, J. Backman, 2001, Clinical pharmacology and therapeutics.

Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans

P. Neuvonen, M. Niemi, J. Backman, 2019, Drug Metabolism and Disposition.

Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction

P. Neuvonen, M. Scheinin, M. Turpeinen, 2012, European Journal of Clinical Pharmacology.

Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics

M. Niemi, J. Backman, M. Neuvonen, 2021, Clinical and translational science.

Analgesic Plasma Concentrations of Oxycodone After Surgery for Breast Cancer—Which Factors Matter?

E. Kalso, P. Neuvonen, M. Niemi, 2018, Clinical pharmacology and therapeutics.

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide

P. Neuvonen, M. Niemi, M. Neuvonen, 2008, Journal of clinical pharmacology.

Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinide.

P. Neuvonen, J. Backman, M. Neuvonen, 2004, British journal of clinical pharmacology.

CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine

T. Bousema, M. Niemi, C. Drakeley, 2014, Malaria Journal.

Genomewide Association Study of Simvastatin Pharmacokinetics

M. Niemi, J. Backman, M. Neuvonen, 2022, Clinical pharmacology and therapeutics.

Effect of rifampicin on the pharmacokinetics of pioglitazone

P. Neuvonen, J. Backman, M. Neuvonen, 2005 .

The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction

M. Niemi, J. Backman, J. Sinisalo, 2023, Atherosclerosis plus.

The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

M. Neuvonen, Tuomas O. Lilius, Eija A Kalso, 2014, European journal of pain.

Rifampicin markedly decreases the exposure to oral and intravenous tramadol

P. Neuvonen, M. Scheinin, K. Laine, 2012, European Journal of Clinical Pharmacology.

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

P. Neuvonen, K. Laine, M. Neuvonen, 2010, European Journal of Clinical Pharmacology.

Autoinhibition of CYP3A4 Leads to Important Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

P. Neuvonen, J. Backman, M. Neuvonen, 2013, Drug Metabolism and Disposition.

Autoinhibition of CYP3A4 Leads to Major Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

P. Neuvonen, J. Backman, M. Neuvonen, 2012 .

CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe

P. Neuvonen, M. Niemi, J. Backman, 2009, Drug Metabolism and Disposition.

Pharmacokinetics and Disposition

F. Nosten, K. Stepniewska, E. Ashley, 2009 .

Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4.

M. Neuvonen, Minna Lehtisalo, Mikko Niemi, 2024, Clinical pharmacology and therapeutics.

Autoinhibition of CYP3A4 Leads to Major Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

M. Neuvonen, Anne M. Filppula, J. Laitila, 2012 .